Huang Dan, Chen Chiqi, Xie Li, Yu Zhuo, Zheng Junke
Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Blood Sci. 2019 Sep 17;1(1):12-18. doi: 10.1097/BS9.0000000000000012. eCollection 2019 Aug.
Hematopoietic stem cells (HSCs) are considered to originate from the aorta-gonad-mesonephros, migrate into fetal liver for a rapid expansion, and eventually reside into a unique hypoxic bone marrow niche, where they maintain their homeostasis throughout their life span. HSCs have been widely used for the treatment of many begin or malignant hematopoietic disorders. However, the unavailability of sufficient amount of HSCs still impedes their applications in the clinic. It is urgent to understand how HSC stemness or cell fates are determined at different developmental stages. Although many intrinsic and extrinsic factors (niche components) have been identified in the regulation of HSC origination, expansion, migration, and localization, the underlying mechanisms remain largely unknown. In this article, we summarize current views on the metabolic profiles of HSCs and related regulatory networks, which shows that intrinsic metabolic regulation may be critical for the cell fate determinations of HSCs: HSCs utilize glycolysis as their major energy sources; mitochondrial respiration is also required for the homeostasis of HSCs; amino acids, lipids, or other nutrient metabolisms also have unique roles in sustaining HSC activities. Mechanistically, many important regulatory pathways, such as MEIS1/HIF1A, MYC, PPM1K/CDC20, and ROS signals, are identified to fine-tune the nutrient metabolisms and cell fate commitments in HSCs. Nevertheless, more effort is required for the optimization or establishment of sensitive and specific metabolic techniques/systems for the metabolism studies in HSCs with limited cell numbers and exploring the metabolic profiles and fundamental regulatory mechanisms of different types of nutrients at each developmental stage of HSCs.
造血干细胞(HSCs)被认为起源于主动脉-性腺-中肾,迁移至胎儿肝脏进行快速扩增,最终定居于独特的低氧骨髓微环境中,并在整个生命周期内维持其稳态。造血干细胞已被广泛用于治疗多种良性或恶性造血系统疾病。然而,难以获得足够数量的造血干细胞仍然阻碍了它们在临床上的应用。迫切需要了解造血干细胞干性或细胞命运在不同发育阶段是如何被决定的。尽管在造血干细胞的起源、扩增、迁移和定位的调控中已经鉴定出许多内在和外在因素(微环境成分),但其潜在机制仍 largely 未知。在本文中,我们总结了关于造血干细胞代谢谱和相关调控网络的当前观点,这表明内在代谢调控可能对造血干细胞的细胞命运决定至关重要:造血干细胞利用糖酵解作为其主要能量来源;线粒体呼吸对于造血干细胞的稳态也是必需的;氨基酸、脂质或其他营养物质代谢在维持造血干细胞活性方面也具有独特作用。从机制上讲,许多重要的调控途径,如 MEIS1/HIF1A、MYC、PPM1K/CDC20 和 ROS 信号,被确定可微调造血干细胞中的营养物质代谢和细胞命运决定。然而,需要付出更多努力来优化或建立针对有限细胞数量的造血干细胞代谢研究的灵敏且特异的代谢技术/系统,并探索造血干细胞每个发育阶段不同类型营养物质的代谢谱和基本调控机制。